Why Great Science Still Fails
Details
Great science doesn’t protect a Medtech startup from bad assumptions & losing time, capital, and credibility with the wrong problem & story.
#### Medtech and biopharma companies lose time, capital, and credibility when they solve the wrong problem, pitch investors the wrong story, mistake interest for traction, or build evidence for approval without planning for adoption.
#### Join Katherine King French, MBA, Director of Strategy at Smith+Nephew, and Bill Schick, MBA, Strategic Growth Advisor for Medtech, Biopharma, and Life Sciences, for a hands-on MDG Boston Lunch & Learn Masterclass.
Grounded in research, market data, company stories, and more than 25 years of startup, investor, commercialization, and IPO experience, the session will unpack seven costly mistakes that can derail a raise, pilot, launch, or next stage of growth.
You will use a practical founder workbook to pressure-test your assumptions and identify weaknesses in your commercial story, evidence, traction, audience, and adoption plan.
You will leave with a clearer view of your biggest risks and a focused 30-day action plan for what to validate, fix, and move forward next.